Pregabalin: Drug Profile and Safety Information
What is Pregabalin?
Pregabalin is a prescription medication belonging to a class of drugs called gabapentinoids, which are anticonvulsants that also treat nerve pain. It is primarily used to manage neuropathic pain, epilepsy, and anxiety disorders. Pregabalin works by reducing abnormal electrical activity in the brain and nervous system that can cause seizures and pain signals.
Uses
Pregabalin is approved for several medical conditions:
- Diabetic peripheral neuropathy: Treats nerve pain in the hands and feet caused by diabetes-related nerve damage
- Postherpetic neuralgia: Manages persistent pain following shingles infections
- Partial seizures: Used as add-on therapy to control certain types of epileptic seizures in adults
- Fibromyalgia: Helps reduce widespread muscle pain and tenderness associated with this chronic condition
- Generalized anxiety disorder: Approved in some countries for treating chronic anxiety symptoms
How it works
Pregabalin binds to calcium channels in nerve cells, reducing the release of neurotransmitters that carry pain signals and cause seizures. By blocking these channels, the medication decreases abnormal nerve activity in both the brain and peripheral nervous system. This action helps control seizures, reduce nerve pain, and calm overactive neural pathways associated with anxiety.
Side effects
Common side effects include:
- Dizziness and drowsiness
- Weight gain
- Swelling in hands and feet
- Blurred or double vision
- Dry mouth
- Difficulty concentrating
- Increased appetite
- Constipation
Serious side effects requiring immediate medical attention:
- Severe allergic reactions with swelling of face, lips, or throat
- Suicidal thoughts or behavior changes
- Severe muscle weakness or pain
- Heart problems or unusual bleeding
- Severe skin reactions or blistering
Warnings and precautions
- Pregnancy and breastfeeding: Pregabalin may cause harm to developing babies and passes into breast milk. Women should discuss risks and benefits with their healthcare provider before use during pregnancy or while nursing.
- Kidney function: Dosage adjustments are necessary for patients with kidney disease, as the drug is primarily eliminated through the kidneys.
- Mental health monitoring: Patients should be closely monitored for signs of depression, suicidal thoughts, or unusual mood changes, especially when starting treatment.
- Dependence potential: Pregabalin has potential for abuse and dependence, particularly in individuals with a history of substance abuse.
- Driving and machinery: The medication can cause dizziness and drowsiness, potentially impairing the ability to drive or operate machinery safely.
Interactions
Several medications and substances can interact with pregabalin:
- Alcohol: Increases drowsiness and dizziness, potentially causing dangerous sedation
- Opioid pain medications: Combined use may increase risk of respiratory depression and severe sedation
- Benzodiazepines: Enhances sedative effects and may cause excessive drowsiness
- Sleep medications: Compounds sedating effects and may impair cognitive function
- Antihistamines: May increase drowsiness and reduce alertness
- Blood pressure medications: ACE inhibitors may increase risk of swelling when combined with pregabalin
- Diabetes medications: May enhance blood sugar-lowering effects, requiring glucose monitoring
- Muscle relaxants: Can increase sedation and muscle weakness
Check interactions with the GMJ Interaction Checker
Dosage
Pregabalin dosages vary depending on the condition being treated and individual patient factors. For neuropathic pain, typical starting doses range from 150-300 mg daily, divided into two or three doses, with maximum doses up to 600 mg daily. For seizure control, doses typically start at 150 mg daily and may be increased to 600 mg daily based on response and tolerability. Fibromyalgia treatment usually begins with 75 mg twice daily, potentially increasing to 150-225 mg twice daily.
Dosage adjustments are required for patients with kidney impairment, and the medication should be tapered gradually when discontinuing to avoid withdrawal symptoms. Healthcare providers will determine the appropriate starting dose and adjustment schedule based on individual medical history, kidney function, and treatment response.
Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.
Cite this page
GMJ News Desk. "Pregabalin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/pregabalin/
This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).Was this article helpful?


